222 related articles for article (PubMed ID: 34722253)
1. Recent Advances of Manganese-Based Hybrid Nanomaterials for Cancer Precision Medicine.
Liu X; Rong P
Front Oncol; 2021; 11():707618. PubMed ID: 34722253
[TBL] [Abstract][Full Text] [Related]
2. Mn
Devreux M; Henoumont C; Dioury F; Boutry S; Vacher O; Elst LV; Port M; Muller RN; Sandre O; Laurent S
Inorg Chem; 2021 Mar; 60(6):3604-3619. PubMed ID: 33625836
[TBL] [Abstract][Full Text] [Related]
3. Integration of gadolinium in nanostructure for contrast enhanced-magnetic resonance imaging.
Marasini R; Thanh Nguyen TD; Aryal S
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jan; 12(1):e1580. PubMed ID: 31486295
[TBL] [Abstract][Full Text] [Related]
4. Nephrogenic system fibrosis: a radiologist's practical perspective.
Martin DR
Eur J Radiol; 2008 May; 66(2):220-4. PubMed ID: 18321672
[TBL] [Abstract][Full Text] [Related]
5. Strategic reconstruction of macrophage-derived extracellular vesicles as a magnetic resonance imaging contrast agent.
Rayamajhi S; Marasini R; Nguyen TDT; Plattner BL; Biller D; Aryal S
Biomater Sci; 2020 May; 8(10):2887-2904. PubMed ID: 32300771
[TBL] [Abstract][Full Text] [Related]
6. Bioinspired, Manganese-Chelated Alginate-Polydopamine Nanomaterials for Efficient in Vivo T
Addisu KD; Hailemeskel BZ; Mekuria SL; Andrgie AT; Lin YC; Tsai HC
ACS Appl Mater Interfaces; 2018 Feb; 10(6):5147-5160. PubMed ID: 29277987
[TBL] [Abstract][Full Text] [Related]
7. Toxicity of magnetic resonance imaging agents: small molecule and nanoparticle.
Chang Y; Lee GH; Kim TJ; Chae KS
Curr Top Med Chem; 2013; 13(4):434-45. PubMed ID: 23432006
[TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy of A High Performance Graphene-Based Magnetic Resonance Imaging Contrast Agent for Renal Abnormalities.
Kanakia S; Toussaint J; Kukarni P; Lee S; Chowdhury SM; Khan S; Mallipattu SK; Shroyer KR; Moore W; Sitharaman B
Graphene Technol; 2016 Dec; 1(1):17-28. PubMed ID: 28261636
[TBL] [Abstract][Full Text] [Related]
9. Orotracheal manganese-enhanced MRI (MEMRI): An effective approach for lung tumor detection.
Bianchi A; Gobbo OL; Dufort S; Sancey L; Lux F; Tillement O; Coll JL; Crémillieux Y
NMR Biomed; 2017 Nov; 30(11):. PubMed ID: 28857310
[TBL] [Abstract][Full Text] [Related]
10. Recent Progress on Manganese-Based Nanostructures as Responsive MRI Contrast Agents.
García-Hevia L; Bañobre-López M; Gallo J
Chemistry; 2019 Jan; 25(2):431-441. PubMed ID: 29999200
[TBL] [Abstract][Full Text] [Related]
11. Tumor Contrast Enhancement and Whole-Body Elimination of the Manganese-Based Magnetic Resonance Imaging Contrast Agent Mn-PyC3A.
Erstad DJ; Ramsay IA; Jordan VC; Sojoodi M; Fuchs BC; Tanabe KK; Caravan P; Gale EM
Invest Radiol; 2019 Nov; 54(11):697-703. PubMed ID: 31356382
[TBL] [Abstract][Full Text] [Related]
12. Recent Advances in Nanotheranostic Agents for Tumor Microenvironment-Responsive Magnetic Resonance Imaging.
Jin L; Yang C; Wang J; Li J; Xu N
Front Pharmacol; 2022; 13():924131. PubMed ID: 35814250
[TBL] [Abstract][Full Text] [Related]
13. Nephrogenic systemic fibrosis: history and epidemiology.
Thomsen HS
Radiol Clin North Am; 2009 Sep; 47(5):827-31, vi. PubMed ID: 19744597
[TBL] [Abstract][Full Text] [Related]
14. The Transition from Metal-Based to Metal-Free Contrast Agents for
Akakuru OU; Iqbal MZ; Saeed M; Liu C; Paunesku T; Woloschak G; Hosmane NS; Wu A
Bioconjug Chem; 2019 Sep; 30(9):2264-2286. PubMed ID: 31380621
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Evaluation of Manganese(II)-Based Ethylenediaminetetraacetic Acid-Ethoxybenzyl Conjugate as a Highly Stable Hepatobiliary Magnetic Resonance Imaging Contrast Agent.
Islam MK; Kim S; Kim HK; Kim YH; Lee YM; Choi G; Baek AR; Sung BK; Kim M; Cho AE; Kang H; Lee GH; Choi SH; Lee T; Park JA; Chang Y
Bioconjug Chem; 2018 Nov; 29(11):3614-3625. PubMed ID: 30383368
[TBL] [Abstract][Full Text] [Related]
16. Magnetic Nanomaterials as Contrast Agents for MRI.
Caspani S; Magalhães R; Araújo JP; Sousa CT
Materials (Basel); 2020 Jun; 13(11):. PubMed ID: 32517085
[TBL] [Abstract][Full Text] [Related]
17. Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting.
Broome DR
Eur J Radiol; 2008 May; 66(2):230-4. PubMed ID: 18372138
[TBL] [Abstract][Full Text] [Related]
18. Revisiting an old friend: manganese-based MRI contrast agents.
Pan D; Caruthers SD; Senpan A; Schmieder AH; Wickline SA; Lanza GM
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(2):162-73. PubMed ID: 20860051
[TBL] [Abstract][Full Text] [Related]
19. Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?
Neuwelt EA; Hamilton BE; Varallyay CG; Rooney WR; Edelman RD; Jacobs PM; Watnick SG
Kidney Int; 2009 Mar; 75(5):465-74. PubMed ID: 18843256
[TBL] [Abstract][Full Text] [Related]
20. A novel manganese chelated macromolecular MRI contrast agent based on O-carboxymethyl chitosan derivatives.
Wang X; Xu L; Ren Z; Fan M; Zhang J; Qi H; Xu M
Colloids Surf B Biointerfaces; 2019 Nov; 183():110452. PubMed ID: 31473409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
